Search results
Here's What is Driving Amgen (AMGN) Stock's Outperformance
Zacks via Yahoo Finance· 1 year agoAmgen AMGN is one of the biggest biotech companies in the world, with a strong presence in the...
20 Countries with Lowest Rates of Cancer
Insider Monkey via Yahoo Finance· 8 months agoIn this article, we will be taking a look at the 20 countries with lowest rates of cancer. If you want to skip our analysis of the oncology industry,...
Here's How Much a $1000 Investment in Amgen Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo Finance· 5 months agoHow much a stock's price changes over time is a significant driver for most investors. Not only can...
Oncolytics (ONCY) Up on Lead Drug Securing 2nd FDA Fast Track Tag
Zacks via Yahoo Finance· 2 years agoOncolytics Biotech (ONCY) receives a fast-track designation from the FDA for pelareorep combined...
2 Best Biotech Stocks to Buy Right Now
Motley Fool· 1 year agoSuccessful investing depends on the ability to both accurately read the present and extrapolate the future. In other words, you need to gauge where a...
The Amgen Inc (AMGN) Company: A Short SWOT Analysis
GuruFocus.com via Yahoo Finance· 8 months agoAmgen Inc (NASDAQ:AMGN) continues to lead in biotechnology-based human therapeutics, with a strong portfolio of flagship drugs. The company's recent...
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 2 weeks agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...
Amgen (AMGN) Valuation: A Comprehensive Analysis of Its Market Value
GuruFocus.com via Yahoo Finance· 8 months agoAs of October 10, 2023, Amgen Inc (NASDAQ:AMGN) experienced a day's loss of -1.02%, with a 3-month...
Amgen (AMGN) Q2 Earnings Beat Estimates, 2023 View Raised
Zacks via Yahoo Finance· 10 months agoAmgen AMGN reported second-quarter 2023 earnings of $5.00 per share, which beat the Zacks Consensus...
How Triple-Refractory Multiple Myeloma Is Treated
Verywell Health via Yahoo News· 2 years agoTriple refractory multiple myeloma usually requires the use of two or more different kinds of drugs to improve survival outcomes and quality of life....
